HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Byung Ha Lee Selected Research

Glioma (Gliomas)

1/2022Long-Acting Recombinant Human Interleukin-7, NT-I7, Increases Cytotoxic CD8 T Cells and Enhances Survival in Mouse Glioma Models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Byung Ha Lee Research Topics

Disease

10Neoplasms (Cancer)
12/2023 - 09/2006
3Inflammation (Inflammations)
08/2021 - 07/2012
3Hyperplasia
10/2007 - 09/2006
3Pathologic Constriction (Stenosis)
10/2007 - 09/2006
2Lymphopenia (Lymphocytopenia)
12/2022 - 01/2022
2Autoimmune Diseases (Autoimmune Disease)
07/2012 - 01/2010
2Thrombosis (Thrombus)
10/2007 - 05/2007
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
12/2023
1Cytokine Release Syndrome
10/2023
1Graft vs Host Disease (Graft-Versus-Host Disease)
10/2023
1cell-associated neurotoxicity
10/2023
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
11/2022
1Tertiary Lymphoid Structures
11/2022
1Hematologic Neoplasms (Hematological Malignancy)
01/2022
1Glioblastoma (Glioblastoma Multiforme)
01/2022
1Glioma (Gliomas)
01/2022
1Triple Negative Breast Neoplasms
08/2021
1Arthrogryposis renal dysfunction cholestasis syndrome
04/2021
1Leukemia
07/2020
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2016
1Cognitive Dysfunction
01/2013

Drug/Important Bio-Agent (IBA)

6Interleukin-7 (Interleukin 7)IBA
10/2023 - 01/2020
5efineptakin alfaIBA
12/2023 - 01/2020
4CytokinesIBA
11/2022 - 07/2012
3Chimeric Antigen ReceptorsIBA
10/2023 - 07/2020
3Paclitaxel (Taxol)FDA LinkGeneric
10/2007 - 09/2006
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2023 - 10/2023
2Proteins (Proteins, Gene)FDA Link
10/2023 - 01/2016
2Therapeutic UsesIBA
07/2020 - 01/2016
2Interleukin-17 (Interleukin 17)IBA
01/2016 - 07/2012
2Polytetrafluoroethylene (Teflon)FDA Link
10/2007 - 09/2006
2Phenobarbital (Luminal)FDA Link
05/2007 - 09/2006
1CD2 AntigensIBA
12/2023
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
10/2023
1B-Cell Maturation AntigenIBA
10/2023
1B7-H1 AntigenIBA
11/2022
1Cancer VaccinesIBA
02/2022
1Temozolomide (Temodar)FDA LinkGeneric
01/2022
1ChemokinesIBA
08/2021
1Docetaxel (Taxotere)FDA Link
08/2021
1Carboplatin (JM8)FDA LinkGeneric
08/2021
1Interferon-gamma (Interferon, gamma)IBA
08/2021
1fructosyl arginineIBA
04/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2020
1AntigensIBA
07/2020
1LigandsIBA
01/2016
1Imiquimod (Aldara)FDA LinkGeneric
01/2016
1AutoantibodiesIBA
01/2013
1Interleukin-27 (Interleukin 27)IBA
07/2012
1InterleukinsIBA
01/2010
1tetrafluoroethylene (tetrafluoroethene)IBA
05/2007

Therapy/Procedure

5Therapeutics
12/2023 - 02/2022
4Immunotherapy
11/2022 - 01/2020
1Radiotherapy
01/2022
1Neoadjuvant Therapy
08/2021
1Renal Dialysis (Hemodialysis)
05/2007
1Stents
09/2006